VaramirStart free · no cardSign in
OMER as of Oct 31 · 23:14 ET
OMERNasdaqPharmaceutical Preparations

Omeros Corp · Brief

Next report

11 days

Nov 12 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
3 of 8≥ implied
avg implied
±12.9%
avg realized
±13.5%
Mar 31 '25±17.5%▼−3.77%×0.22
May 15 '25±7.8%▼−18.61%×2.38
Aug 14 '25±10.8%▲+7.04%×0.65
Q3 FY25±13.1%▲+25.32%×1.93
Jan 7 '26±15.0%▼−4.54%×0.30
Q1 FY26±15.9%▲+14.39%×0.91
May 13 '26±10.6%▼−7.65%×0.72
Q2 FY26±12.3%▲+26.55%×2.15
quarterimplied−30%0+30%realized×
Q2 FY26±12.3%▲+26.55%×2.15
May '26±10.6%▼−7.65%×0.72
Q1 FY26±15.9%▲+14.39%×0.91
Jan '26±15.0%▼−4.54%×0.30
Q3 FY25±13.1%▲+25.32%×1.93
Aug '25±10.8%▲+7.04%×0.65
2 older reports
May '25±7.8%▼−18.61%×2.38
Mar '25±17.5%▼−3.77%×0.22
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 12 report · est.

Bull2 of 3

9disclosed supplier and customer ties in SEC filingsSEC filings
171managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

5 of 8recent reports where the move came in under the options implied rangeEarnings history
3 of 18of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 27 '26once per report · top 2 per case

Linked exposure

OMER report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 29impliedImplied move: ±12.4% into Nov 12 earnings (Oct 29 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.